The Genome Sequence of Yaba-Like Disease Virus, a Yatapoxvirus

Total Page:16

File Type:pdf, Size:1020Kb

The Genome Sequence of Yaba-Like Disease Virus, a Yatapoxvirus Virology 281, 170–192 (2001) doi:10.1006/viro.2000.0761, available online at http://www.idealibrary.com on View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector The Genome Sequence of Yaba-like Disease Virus, a Yatapoxvirus Han-Joo Lee,*,1 Karim Essani,† and Geoffrey L. Smith*,2 *Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, United Kingdom; and †Department of Biological Sciences, Western Michigan University, Michigan 49008 Received July 18, 2000; returned to author for revision August 18, 2000; accepted November 28, 2000 The genome sequence of Yaba-like disease virus (YLDV), an unclassified member of the yatapoxvirus genus, has been determined. Excluding the terminal hairpin loops, the YLDV genome is 144,575 bp in length and contains inverted terminal repeats (ITRs) of 1883 bp. Within 20 nucleotides of the termini, there is a sequence that is conserved in other poxviruses and is required for the resolution of concatemeric replicative DNA intermediates. The nucleotide composition of the genome is 73% AϩT, but the ITRs are only 63% AϩT. The genome contains 151 tightly packed open reading frames (ORFs) that either are Ն180 nucleotides in length or are conserved in other poxviruses. ORFs within 23 kb of each end are transcribed toward the termini, whereas ORFs within the central region of the genome are encoded on either DNA strand. In the central region ORFs have a conserved position, orientation, and sequence compared with vaccinia virus ORFs and encode many enzymes, transcription factors, or structural proteins. In contrast, ORFs near the termini are more divergent and in seven cases are without counterparts in other poxviruses. The YLDV genome encodes several predicted immunomodulators; examples include two proteins with similarity to CC chemokine receptors and predicted secreted proteins with similarity to MHC class I antigen, OX-2, interleukin-10/mda-7, poxvirus growth factor, serpins, and a type I interferon-binding protein. Phylogenic analyses indicated that YLDV is very closely related to yaba monkey tumor virus, but outside the yatapoxvirus genus YLDV is more closely related to swinepox virus and leporipoxviruses than to other chordopoxvirus genera. © 2001 Academic Press Key Words: yatapoxvirus; genome sequence; phylogeny; virus evolution; immune evasion. INTRODUCTION 1994), India-1968 (Shchelkunov et al., 1995), and Garcia- 1966 (Shchelkunov et al., 2000), molluscum contagiosum Poxviruses are large DNA viruses that infect insects virus (MCV) (Senkevich et al., 1997), Melanoplus sangui- (entomopoxviruses) or vertebrates (chordopoxviruses) nipes entomopoxvirus (MSV) (Afonso et al., 1999), Shope (Fenner, 1996). The chordopoxvirus group is divided into fibroma virus (SFV) (Willer et al., 1999), myxoma virus eight genera, orthopox, parapox, capripox, leporipox, sui- (MYX) (Cameron et al., 1999), fowlpox virus (FPV) (Afonso pox, avipox, molluscipox, and yatapox, of which the or- et al., 2000), and camelpox virus (CMPV) (Gubser and thopoxviruses have been the most important for humans and include variola virus (VAR) (the cause of smallpox), Smith, submitted for publication). vaccinia virus (VV) (the vaccine used to eradicate small- The yatapoxvirus genus contains three members: ta- pox), cowpox virus (CPV), and monkeypox virus. All pox- napox virus (TPV), yaba monkey tumor virus (YMTV), and viruses replicate in the cell cytoplasm and encode their yaba-like disease virus (YLDV) (Knight et al., 1989). All own enzymes for transcription and DNA replication these viruses are morphologically similar to orthopoxvi- (Moss, 1996). ruses but are antigenically distinct from members of this The nucleotide sequence of several poxviruses has and other poxvirus genera and hence cannot be neutral- been determined. These include VV strains Copenhagen ized by polyclonal antisera raised against VV, MCV, or orf (CPN) (Goebel et al., 1990), modified virus Ankara virus (OV), a parapoxvirus (Downie et al., 1971). Yatapox- (Antoine et al., 1998), and the majority of Western Re- viruses have a narrow host range and infect monkeys but serve (WR) (Smith et al., 1991, and references therein), can also be transmitted to humans where they may VAR strains Bangladesh-1975 (VAR-BSH) (Massung et al., cause a mild febrile illness lasting a few days with one or two lesions (deHarven and Yohn, 1966; Espan˜a et al., 1971). The progression of yatapoxvirus-induced pathol- Sequence data from this article have been deposited with the EMBL ogy is considerably slower than that for orthopoxviruses. Data Library under Accession No. AJ293568. TPV was isolated from the skin lesions of patients during 1 Present address: Memorial Slone-Kettering Cancer Center, 1275 outbreaks in the Tana River valley in Kenya in 1957 to York Avenue, RRL 629, Box 362, New York, NY 10021. 1962 (Downie et al., 1971). YMTV was isolated from a 2 To whom correspondence and reprint requests should be ad- dressed at present address: Wright-Fleming Institute, Imperial College colony of rhesus monkeys near Lagos, West Africa in School of Medicine, St. Mary’s Campus, Norfolk Place, London W2 1958 (Bearcroft and Jamieson, 1958) and can produce 1PG, United Kingdom. Fax: 0207-592-3973. E-mail: [email protected]. tumor-like lesions with masses of mesodermal tissue 0042-6822/01 $35.00 Copyright © 2001 by Academic Press 170 All rights of reproduction in any form reserved. GENOME SEQUENCE OF YLDV 171 (Niven et al., 1961). YLDV was isolated in 1965–1966 from monkeys and animal handlers in primate centers in the United States (Casey et al., 1967; Hall and McNulty, 1967; Nicholas and McNulty, 1968; Espan˜a, 1971). The YLDV- induced lesions in monkeys and clinical signs in humans are similar to TPV and these viruses are biologically indistinguishable (McNulty et al., 1968; Downie and Es- pan˜a, 1972). Serological cross-reactivity between yata- poxviruses has been reported (Nicholas and McNulty, 1968; Kupper et al., 1970). Yatapoxviruses have a 145-kb, linear, double-stranded (ds) DNA genome with covalently closed hairpin ends and variations have been noted in the restriction patterns of the different viruses (Knight et al., 1989). Cross-hybrid- ization experiments indicated some sequence conserva- tion between YMTV and monkeypox virus (Rouhandeh et al., 1982), but until recently very little sequence data were available for the yatapoxviruses. Part of the YMTV ge- nome was deposited in a public database (Amano et al., 1995, 2000a, b; Amano and Miyamura, 2000) and small fragments of the TPV genome have been sequenced (Neering and Essani, 1999). To gain an increased understanding of the yatapoxvi- ruses and their evolutionary relationships with other pox- viruses, we have determined the sequence of YLDV with FIG. 1. Schematic representation of the YLDV ITRs. Each ITR is the exception of the terminal hairpins. The genome is shown together with the positions of the terminal ORFs, the concate- 144,575 bp and contains 151 open reading frames mer resolution sequence, and the presumed terminal hairpin. Shown (ORFs). The ORFs within the central 100 kb of the ge- beneath the right ITR is the concatemeric resolution sequence from VV, nome show considerable similarity to corresponding MCV, FPV, SFV, and YLDV. Nucleotides conserved in at least four of five sequences are boxed. ORFs in VV in their deduced amino acid sequence, po- sition, and direction of transcription. Several potential immunomodulators are identified and the evolutionary of the virus genome is unknown. However, several lines relationship of YLDV with other poxviruses is discussed. of evidence indicate that the sequence obtained came very close to the terminal hairpins. First, the length ob- RESULTS AND DISCUSSION tained (144,575 bp) was very similar to the total length of the YLDV genome (146.5 bp) estimated from restriction Genome structure of YLDV enzyme digestion and gel electrophoresis (Knight et al., A total of 1,098,770 nucleotides of YLDV DNA were 1989). Second, the size of the terminal PstI restriction assembled into a contiguous sequence of 144,575 bp. fragments described by others (Knight et al., 1989) and Ninety-seven point nine percent of these data were ob- observed experimentally by us was indistinguishable tained from sequencing random clones and the remain- from the length predicted by computer from the se- ing 2.1% were obtained from direct sequencing of either quence generated here. Third, and most compelling, a genomic DNA or 10-kb clones using specific oligonucle- sequence motif was identified within 20 nucleotides of otide primers. The average character density was 7.6 per each terminus that is conserved perfectly with se- nucleotide and 99.0% of the sequence was obtained from quences found very close to the terminal hairpins of both DNA strands. Every position was sequenced at other poxviruses and known to be required for the res- least twice. The genome was composed of 73% AϩT, olution of concatemeric DNA replicative intermediates making YLDV the most AϩT-rich chordopoxvirus to have (Merchlinsky and Moss, 1989) (Fig. 1). In VV strains WR been sequenced. Only the genome of the entomopoxvi- (Baroudy et al., 1982) and CPN (Goebel et al., 1990) and rus MSV has a higher AϩT content (81%) (Afonso et al., VAR-BSH (Massung et al., 1994) this conserved se- 1999). quence is located within 60 bp of the terminal hairpins. The sequence obtained did not include the terminal The motif is also present in FPV (Afonso et al., 2000), SFV hairpins because, as expected, these were not cloned and MYX (Cameron et al., 1999; Willer et al., 1999), and into either library and attempts to sequence these di- MCV (Senkevich et al., 1996). This observation extended rectly using virus DNA as template and specific oligonu- the number of chordopoxvirus genera known to contain cleotides were unsuccessful. Therefore, the exact length this sequence and suggested that the mechanism of 172 LEE, ESSANI, AND SMITH FIG. 2. YLDV genetic map.
Recommended publications
  • JOURNAL of VIROLOGY Volume 18 Contents for May Number 2
    JOURNAL OF VIROLOGY Volume 18 Contents for May Number 2 Animal Viruses Isolation and Properties of the Replicase of Encephalomyocarditis Virus. A. TRAUB,* B. DISKIN, H. ROSENBERG, AND E. KALMAR ...... ............... 375 Synthesis and Integration of Viral DNA in Chicken Cells at Different Times After Infection with Various Multiplicities of Avian Oncornavirus. ALLAN T. KHOURY* AND HIDESABURO HANAFUSA ........ .......................... 383 RNA Metabolism of Murine Leukemia Virus. III. Identification and Quantitation of Endogenous Virus-Specific mRNA in the Uninfected BALB/c Cell Line JLS-V9. HUNG FAN AND NIKOLAUS MUELLER-LANTZSCH* ..... ............ 401 Endogenous Ecotropic Mouse Type C Viruses Deficient in Replication and Produc- tion of XC Plaques. ULF W RAPP AND ROBERT C. NoWINSKI* ..... ....... 411 Further Characterization of the Friend Murine Leukemia Virus Reverse Tran- scriptase-RNase H Complex. KARIN MOELLING ...... ................... 418 State of the Viral DNA in Rat Cells Transformed by Polyoma Virus. I. Virus Res- cue and the Presence of Nonintegrated Viral DNA Molecules. ISHWARI PRASAD, DIMITRIS ZOUZIAS, AND CLAUDIO BASIUCO* ...... ................ 436 Inhibition of Infectious Rous Sarcoma Virus Production by a Rifamycin Deriva- tive. CHARLES SZABO,* MINA J. BISSELL, AND MELVIN CALVIN ..... ...... 445 Synthesis ofthe Adenovirus-Coded DNA Binding Protein in Infected Cells. ZVEE GILEAD,* KINJI SUGUWARA, G. SHANMUGAM, AND MAURICE GREEN ....... 454 Intracellular Distribution and Sedimentation Properties of Virus-Specific RNA in Two Clones of BHK Cells Transformed by Polyoma Virus. IAN H. MAX- WELL .............................................................. 461 Inherited Resistance to N- and B-Tropic Murine Leukemia Viruses In Vitro: Titration Patterns in Strains SIM and SIM.R Congenic at the Fv-1 Locus. VERA SCHUH, MARTIN E. BLACKSTEIN, AND ARTHUR A.
    [Show full text]
  • TNF Decoy Receptors Encoded by Poxviruses
    pathogens Review TNF Decoy Receptors Encoded by Poxviruses Francisco Javier Alvarez-de Miranda † , Isabel Alonso-Sánchez † , Antonio Alcamí and Bruno Hernaez * Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Campus de Cantoblanco, Universidad Autónoma de Madrid, Nicolás Cabrera 1, 28049 Madrid, Spain; [email protected] (F.J.A.-d.M.); [email protected] (I.A.-S.); [email protected] (A.A.) * Correspondence: [email protected]; Tel.: +34-911-196-4590 † These authors contributed equally. Abstract: Tumour necrosis factor (TNF) is an inflammatory cytokine produced in response to viral infections that promotes the recruitment and activation of leukocytes to sites of infection. This TNF- based host response is essential to limit virus spreading, thus poxviruses have evolutionarily adopted diverse molecular mechanisms to counteract TNF antiviral action. These include the expression of poxvirus-encoded soluble receptors or proteins able to bind and neutralize TNF and other members of the TNF ligand superfamily, acting as decoy receptors. This article reviews in detail the various TNF decoy receptors identified to date in the genomes from different poxvirus species, with a special focus on their impact on poxvirus pathogenesis and their potential use as therapeutic molecules. Keywords: poxvirus; immune evasion; tumour necrosis factor; tumour necrosis factor receptors; lymphotoxin; inflammation; cytokines; secreted decoy receptors; vaccinia virus; ectromelia virus; cowpox virus Citation: Alvarez-de Miranda, F.J.; Alonso-Sánchez, I.; Alcamí, A.; 1. TNF Biology Hernaez, B. TNF Decoy Receptors TNF is a potent pro-inflammatory cytokine with a broad range of biological effects, Encoded by Poxviruses. Pathogens ranging from the activation of inflammatory gene programs to cell differentiation or 2021, 10, 1065.
    [Show full text]
  • Escherichia Coli Saccharomyces Cerevisiae Bacillus Subtilis はB
    研究開発等に係る遺伝子組換え生物等の第二種使用等に当たって執るべき拡散防止措 置等を定める省令の規定に基づき認定宿主ベクター系等を定める件 (平成十六年一月二十九日文部科学省告示第七号) 最終改正:令和三年二月十五日文部科学省告示第十三号 (認定宿主ベクター系) 第一条 研究開発等に係る遺伝子組換え生物等の第二種使用等に当たって執るべき拡散防止 措置等を定める省令(以下「省令」という。)第二条第十三号の文部科学大臣が定める認 定宿主ベクター系は、別表第一に掲げるとおりとする。 (実験分類の区分ごとの微生物等) 第二条 省令第三条の表第一号から第四号までの文部科学大臣が定める微生物等は、別表第 二の上欄に掲げる区分について、それぞれ同表の下欄に掲げるとおりとする。 (特定認定宿主ベクター系) 第三条 省令第五条第一号ロの文部科学大臣が定める特定認定宿主ベクター系は、別表第一 の2の項に掲げる認定宿主ベクター系とする。 (自立的な増殖力及び感染力を保持したウイルス及びウイロイド) 第四条 省令別表第一第一号ヘの文部科学大臣が定めるウイルス及びウイロイドは、別表第 三に掲げるとおりとする。 別表第1(第1条関係) 区 分 名 称 宿主及びベクターの組合せ 1 B1 (1) EK1 Escherichia coli K12株、B株、C株及びW株又は これら各株の誘導体を宿主とし、プラスミド又は バクテリオファージの核酸であって、接合等によ り宿主以外の細菌に伝達されないものをベクター とするもの(次項(1)のEK2に該当するものを除 く。) (2) SC1 Saccharomyces cerevisiae又はこれと交雑可能な 分類学上の種に属する酵母を宿主とし、これらの 宿主のプラスミド、ミニクロモソーム又はこれら の誘導体をベクターとするもの(次項(2)のSC2 に該当するものを除く。) (3) BS1 Bacillus subtilis Marburg168株、この誘導体又 はB. licheniformis全株のうち、アミノ酸若しく は核酸塩基に対する複数の栄養要求性突然変異を 有する株又は胞子を形成しない株を宿主とし、こ れらの宿主のプラスミド(接合による伝達性のな いものに限る。)又はバクテリオファージの核酸 をベクターとするもの(次項(3)のBS2に該当す るものを除く。) (4) Thermus属細菌 Thermus属細菌(T. thermophilus、T. aquaticus、 T. flavus、T. caldophilus及びT. ruberに限る。) を宿主とし、これらの宿主のプラスミド又はこの 誘導体をベクターとするもの (5) Rhizobium属細菌 Rhizobium属細菌(R. radiobacter(別名Agroba- cterium tumefaciens)及びR. rhizogenes(別名 Agrobacterium rhizogenes)に限る。)を宿主と し、これらの宿主のプラスミド又はRK2系のプラ スミドをベクターとするもの (6) Pseudomonas putida Pseudomonas putida KT2440株又はこの誘導体を 宿主とし、これら宿主への依存性が高く、宿主以 外の細胞に伝達されないものをベクターとするも の (7) Streptomyces属細菌 Streptomyces属細菌(S. avermitilis、S. coel- icolor [S. violaceoruberとして分類されるS. coelicolor A3(2)株を含む]、S. lividans、S. p- arvulus、S. griseus及びS.
    [Show full text]
  • Specimen Type, Collection Methods, and Diagnostic Assays Available For
    Specimen type, collection methods, and diagnostic assays available for the detection of poxviruses from human specimens by the Poxvirus and Rabies Branch, Centers for Disease Control and Prevention1. Specimen Orthopoxvirus Parapoxvirus Yatapoxvirus Molluscipoxvirus Specimen type collection method PCR6 Culture EM8 IHC9,10 Serology11 PCR12 EM8 IHC9,10 PCR13 EM8 PCR EM8 Lesion material Fresh or frozen Swab 5 Lesion material [dry or in media ] [vesicle / pustule Formalin fixed skin, scab / crust, etc.] Paraffin block Fixed slide(s) Container Lesion fluid Swab [vesicle / pustule [dry or in media5] fluid, etc.] Touch prep slide Blood EDTA2 EDTA tube 7 Spun or aliquoted Serum before shipment Spun or aliquoted Plasma before shipment CSF3,4 Sterile 1. The detection of poxviruses by electron microscopy (EM) and immunohistochemical staining (IHC) is performed by the Infectious Disease Pathology Branch of the CDC. 2. EDTA — Ethylenediaminetetraacetic acid. 3. CSF — Cerebrospinal fluid. 4. In order to accurately interpret test results generated from CSF specimens, paired serum must also be submitted. 5. If media is used to store and transport specimens a minimal amount should be used to ensure as little dilution of DNA as possible. 6. Orthopoxvirus generic real-time polymerase chain reaction (PCR) assays will amplify DNA from numerous species of virus within the Orthopoxvirus genus. Species-specific real-time PCR assays are available for selective detection of DNA from variola virus, vaccinia virus, monkeypox virus, and cowpox virus. 7. Blood is not ideal for the detection of orthopoxviruses by PCR as the period of viremia has often passed before sampling occurs. 8. EM can reveal the presence of a poxvirus in clinical specimens or from virus culture, but this technique cannot differentiate between virus species within the same genus.
    [Show full text]
  • ICTV Code Assigned: 2011.001Ag Officers)
    This form should be used for all taxonomic proposals. Please complete all those modules that are applicable (and then delete the unwanted sections). For guidance, see the notes written in blue and the separate document “Help with completing a taxonomic proposal” Please try to keep related proposals within a single document; you can copy the modules to create more than one genus within a new family, for example. MODULE 1: TITLE, AUTHORS, etc (to be completed by ICTV Code assigned: 2011.001aG officers) Short title: Change existing virus species names to non-Latinized binomials (e.g. 6 new species in the genus Zetavirus) Modules attached 1 2 3 4 5 (modules 1 and 9 are required) 6 7 8 9 Author(s) with e-mail address(es) of the proposer: Van Regenmortel Marc, [email protected] Burke Donald, [email protected] Calisher Charles, [email protected] Dietzgen Ralf, [email protected] Fauquet Claude, [email protected] Ghabrial Said, [email protected] Jahrling Peter, [email protected] Johnson Karl, [email protected] Holbrook Michael, [email protected] Horzinek Marian, [email protected] Keil Guenther, [email protected] Kuhn Jens, [email protected] Mahy Brian, [email protected] Martelli Giovanni, [email protected] Pringle Craig, [email protected] Rybicki Ed, [email protected] Skern Tim, [email protected] Tesh Robert, [email protected] Wahl-Jensen Victoria, [email protected] Walker Peter, [email protected] Weaver Scott, [email protected] List the ICTV study group(s) that have seen this proposal: A list of study groups and contacts is provided at http://www.ictvonline.org/subcommittees.asp .
    [Show full text]
  • Novel Poxvirus in Proliferative Lesions of Wild Rodents in East Central Texas, USA
    DISPATCHES Novel Poxvirus in Proliferative Lesions of Wild Rodents in East Central Texas, USA Carolyn L. Hodo, Matthew R. Mauldin, on the hind feet and tail (Figure 1, panel A) but otherwise Jessica E. Light, Kimberly Wilkins, appeared healthy. In April 2017, at the Biodiversity Re- Shiyuyun Tang, Yoshinori Nakazawa, search and Teaching Collections at Texas A&M University Ginny L. Emerson, Jana M. Ritter, in College Station, Texas (160 km north of the first local- Joanne L. Mansell, Sarah A. Hamer ity), we captured an additional adult male B. taylori mouse (mouse 2) with mild 1–2-mm proliferative lesions on the Northern pygmy mice from 2 localities in east central left hind foot and tail. Both animals were euthanized in ac- Texas, USA, had proliferative epidermal lesions on the tail cordance with Texas Parks and Wildlife Department scien- and feet. Electron microscopy of lesion tissue revealed pox- tific collections permit (SPR-0512-917) and Texas A&M virus. Phylogenetic analyses indicated the virus differed 35% from its closest relatives, the Chordopoxvirinae. Future University Institutional Animal Care and Use Commit- research is needed to determine whether this virus could tee’s animal use protocol (2015-0088). These 2 B. taylori affect human health. specimens are housed at Biodiversity Research and Teach- ing Collections (mammal voucher nos. TCWC 65223 and TCWC 65224; http://portal.vertnet.org/search). hordopoxvirinae is a diverse subfamily of viruses We subjected mouse 1 to a full necropsy and found Cwithin Poxviridae. These geographically widespread the mouse to be in good body condition. Extending from viruses infect birds, reptiles, and mammals, and many are the skin of the dorsal aspect of the left hind foot, plantar zoonotic (1).
    [Show full text]
  • Universidad Autónoma De Madrid
    UNIVERSIDAD AUTÓNOMA DE MADRID FACULTAD DE MEDICINA Departamento de Medicina Interna INVESTIGACIÓN DE LA ASOCIACIÓN ENTRE MANIFESTACIONES CUTÁNEAS E INFECCIÓN POR PARVOVIRUS B19 TESIS DOCTORAL Carlos Santonja Garriga Servicio de Anatomía Patológica Fundación Jiménez Díaz, Universidad Autónoma Madrid, 2017 DIRIGIDA POR el Doctor LUIS REQUENA CABALLERO AGRADECIMIENTOS A los Dres Luis Requena y Heinz Kutzner, por su inagotable generosidad A mi padre. Introducción General a) Presentación de los trabajos Los trabajos compendiados que constituyen el cuerpo de la presente tesis están relacionados con la infección por el Parvovirus humano B19 (B19V), los cuadros dermatopatológicos ocasionados por la misma y la hipótesis de que la detección aislada en biopsias cutáneas de ácido desoxirribonucleico (ADN) de B19V no constituye necesariamente prueba de relación causal entre aquella y estos, pues el virus es capaz de permanecer en los tejidos mucho tiempo después de ocurrida la infección. Tal relación debe basarse en determinaciones analíticas (seroconversión, presencia de ADN vírico en sangre) o confirmación de la presencia de material del virión en los tejidos, como la demostración de proteína vírica (Viral Protein 2, VP2) en el endotelio de vasos dérmicos. Esta última apoya la tesis de que el virus penetra en células generalmente poco permisivas valiéndose de un mecanismo de estímulo mediado por anticuerpos, en el curso de la primera fase de la infección. En el primero de los trabajos (Immunohistochemistry in the Diagnosis of Cutaneous Viral Infections) se detalla la aportación de la inmunohistoquímica al diagnóstico de infección reciente por B19V, en el marco de un estudio global de infecciones víricas de la piel.
    [Show full text]
  • Here, There, and Everywhere: the Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses
    viruses Review Here, There, and Everywhere: The Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses Natalia Ingrid Oliveira Silva, Jaqueline Silva de Oliveira, Erna Geessien Kroon , Giliane de Souza Trindade and Betânia Paiva Drumond * Laboratório de Vírus, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais: Belo Horizonte, Minas Gerais 31270-901, Brazil; [email protected] (N.I.O.S.); [email protected] (J.S.d.O.); [email protected] (E.G.K.); [email protected] (G.d.S.T.) * Correspondence: [email protected] Abstract: The global emergence of zoonotic viruses, including poxviruses, poses one of the greatest threats to human and animal health. Forty years after the eradication of smallpox, emerging zoonotic orthopoxviruses, such as monkeypox, cowpox, and vaccinia viruses continue to infect humans as well as wild and domestic animals. Currently, the geographical distribution of poxviruses in a broad range of hosts worldwide raises concerns regarding the possibility of outbreaks or viral dissemination to new geographical regions. Here, we review the global host ranges and current epidemiological understanding of zoonotic orthopoxviruses while focusing on orthopoxviruses with epidemic potential, including monkeypox, cowpox, and vaccinia viruses. Keywords: Orthopoxvirus; Poxviridae; zoonosis; Monkeypox virus; Cowpox virus; Vaccinia virus; host range; wild and domestic animals; emergent viruses; outbreak Citation: Silva, N.I.O.; de Oliveira, J.S.; Kroon, E.G.; Trindade, G.d.S.; Drumond, B.P. Here, There, and Everywhere: The Wide Host Range 1. Poxvirus and Emerging Diseases and Geographic Distribution of Zoonotic diseases, defined as diseases or infections that are naturally transmissible Zoonotic Orthopoxviruses. Viruses from vertebrate animals to humans, represent a significant threat to global health [1].
    [Show full text]
  • Zoonotic Potential of International Trade in CITES-Listed Species Annexes B, C and D JNCC Report No
    Zoonotic potential of international trade in CITES-listed species Annexes B, C and D JNCC Report No. 678 Zoonotic potential of international trade in CITES-listed species Annex B: Taxonomic orders and associated zoonotic diseases Annex C: CITES-listed species and directly associated zoonotic diseases Annex D: Full trade summaries by taxonomic family UNEP-WCMC & JNCC May 2021 © JNCC, Peterborough 2021 Zoonotic potential of international trade in CITES-listed species Prepared for JNCC Published May 2021 Copyright JNCC, Peterborough 2021 Citation UNEP-WCMC and JNCC, 2021. Zoonotic potential of international trade in CITES- listed species. JNCC Report No. 678, JNCC, Peterborough, ISSN 0963-8091. Contributing authors Stafford, C., Pavitt, A., Vitale, J., Blömer, N., McLardy, C., Phillips, K., Scholz, L., Littlewood, A.H.L, Fleming, L.V. & Malsch, K. Acknowledgements We are grateful for the constructive comments and input from Jules McAlpine (JNCC), Becky Austin (JNCC), Neville Ash (UNEP-WCMC) and Doreen Robinson (UNEP). We also thank colleagues from OIE for their expert input and review in relation to the zoonotic disease dataset. Cover Photographs Adobe Stock images ISSN 0963-8091 JNCC Report No. 678: Zoonotic potential of international trade in CITES-listed species Annex B: Taxonomic orders and associated zoonotic diseases Annex B: Taxonomic orders and associated zoonotic diseases Table B1: Taxonomic orders1 associated with at least one zoonotic disease according to the source papers, ranked by number of associated zoonotic diseases identified.
    [Show full text]
  • Discovery of Antivirals Against Smallpox
    Discovery of antivirals against smallpox Stephen C. Harrisona,b, Bruce Albertsc, Ellie Ehrenfeldd, Lynn Enquiste, Harvey Finebergf, Steven L. McKnightg, Bernard Mossh, Michael O’Donnelli, Hidde Ploeghj, Sandra L. Schmidk, K. Peter Walterl, and Julie Theriotm aHarvard Medical School, Howard Hughes Medical Institute, Seeley Mudd Building, Room 130, 250 Longwood Avenue, Boston, MA 02115; cNational Academy of Sciences, 2101 Constitution Avenue, NW, Washington, DC 20418; dLaboratory of Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 50, Room 6120, 50 South Drive, Bethesda, MD 20892; ePrinceton University, 314 Schultz Laboratory, Washington Road, Princeton, NJ 08544; fInstitute of Medicine, 2101 Constitution Avenue, NW, Washington, DC 20418; gDepartment of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390; hLaboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room 229, 4 Center Drive, Bethesda, MD 20892; iLaboratory of DNA Replication, The Rockefeller University, Howard Hughes Medical Institute, 1230 York Avenue, New York, NY 10021; jDepartment of Pathology, Harvard Medical School, NRB, 77 Avenue Louis Pasteur, Boston, MA 02115; kDepartment of Cell Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; lDepartment of Biochemistry and Biophysics, University of California School of Medicine, Howard Hughes Medical Institute, Box 0448, HSE 1001, San Francisco, CA 94143; and mDepartment of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305 Contributed by Stephen C. Harrison, May 21, 2004 mallpox, a devastating infectious Whatever the likelihood of covertly dopoxviruses has a restricted and spe- disease dreaded throughout much held variola virus stocks, an intentional cific host array (Table 2).
    [Show full text]
  • Commission Directive (Eu)
    L 279/54 EN Offi cial Jour nal of the European Union 31.10.2019 COMMISSION DIRECTIVE (EU) 2019/1833 of 24 October 2019 amending Annexes I, III, V and VI to Directive 2000/54/EC of the European Parliament and of the Council as regards purely technical adjustments THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (1), and in particular Article 19 thereof, Whereas: (1) Principle 10 of the European Pillar of Social Rights (2), proclaimed at Gothenburg on 17 November 2017, provides that every worker has the right to a healthy, safe and well-adapted working environment. The workers’ right to a high level of protection of their health and safety at work and to a working environment that is adapted to their professional needs and that enables them to prolong their participation in the labour market includes protection from exposure to biological agents at work. (2) The implementation of the directives related to the health and safety of workers at work, including Directive 2000/54/EC, was the subject of an ex-post evaluation, referred to as a REFIT evaluation. The evaluation looked at the directives’ relevance, at research and at new scientific knowledge in the various fields concerned. The REFIT evaluation, referred to in the Commission Staff Working Document (3), concludes, among other things, that the classified list of biological agents in Annex III to Directive 2000/54/EC needs to be amended in light of scientific and technical progress and that consistency with other relevant directives should be enhanced.
    [Show full text]
  • BMBL) Quickly Became the Cornerstone of Biosafety Practice and Policy in the United States Upon First Publication in 1984
    Biosafety in Microbiological and Biomedical Laboratories 5th Edition U.S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Institutes of Health HHS Publication No. (CDC) 21-1112 Revised December 2009 Foreword Biosafety in Microbiological and Biomedical Laboratories (BMBL) quickly became the cornerstone of biosafety practice and policy in the United States upon first publication in 1984. Historically, the information in this publication has been advisory is nature even though legislation and regulation, in some circumstances, have overtaken it and made compliance with the guidance provided mandatory. We wish to emphasize that the 5th edition of the BMBL remains an advisory document recommending best practices for the safe conduct of work in biomedical and clinical laboratories from a biosafety perspective, and is not intended as a regulatory document though we recognize that it will be used that way by some. This edition of the BMBL includes additional sections, expanded sections on the principles and practices of biosafety and risk assessment; and revised agent summary statements and appendices. We worked to harmonize the recommendations included in this edition with guidance issued and regulations promulgated by other federal agencies. Wherever possible, we clarified both the language and intent of the information provided. The events of September 11, 2001, and the anthrax attacks in October of that year re-shaped and changed, forever, the way we manage and conduct work
    [Show full text]